PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,333,302 | -5.9% | 542,883 | -4.1% | 0.00% | 0.0% |
| Q2 2023 | $3,542,803 | -14.6% | 565,943 | -35.0% | 0.00% | 0.0% |
| Q1 2023 | $4,150,158 | -42.1% | 870,054 | +5.5% | 0.00% | 0.0% |
| Q4 2022 | $7,173,760 | -44.9% | 824,570 | -24.6% | 0.00% | -66.7% |
| Q3 2022 | $13,008,000 | -19.1% | 1,093,116 | -3.1% | 0.00% | 0.0% |
| Q2 2022 | $16,083,000 | +1098.4% | 1,128,567 | +1650.9% | 0.00% | – |
| Q1 2022 | $1,342,000 | +85.4% | 64,456 | +105.7% | 0.00% | – |
| Q4 2021 | $724,000 | -97.8% | 31,337 | -96.8% | 0.00% | -100.0% |
| Q2 2021 | $33,148,000 | +0.0% | 970,364 | -3.7% | 0.01% | 0.0% |
| Q1 2021 | $33,144,000 | -58.2% | 1,007,723 | -22.8% | 0.01% | -60.0% |
| Q4 2020 | $79,230,000 | +38.7% | 1,305,179 | -20.7% | 0.02% | +25.0% |
| Q3 2020 | $57,139,000 | – | 1,645,822 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $74,726,000 | 44.17% |
| Euclidean Capital LLC | 2,336,909 | $53,983,000 | 30.69% |
| OUP Management Co., LLC | 989,232 | $22,851,000 | 10.30% |
| Nextech Invest Ltd. | 1,385,807 | $32,012,000 | 8.43% |
| Boxer Capital, LLC | 2,838,236 | $65,563,000 | 2.55% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $12,713,000 | 2.38% |
| Orbimed Advisors | 7,330,423 | $169,333,000 | 2.18% |
| Asymmetry Capital Management, L.P. | 97,680 | $2,256,000 | 1.20% |
| RTW INVESTMENTS, LP | 2,980,960 | $68,860,000 | 1.01% |
| HighVista Strategies LLC | 39,777 | $919,000 | 0.73% |